2 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Micelle BioPharma Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Sickle CEll Disease ComplicatioN Trial SC411, Placebo - Sickle Cell Disease | Phase 3 | Unknown | Micelle BioPharma Inc | 210 | 2019-03-01 | 2019-02-01 |
| Dose-Finding Study of SC411 in Children With Sickle Cell Disease Docosahexaenoic Acid, Placebo - Sickle Cell Disease | Phase 2 | Unknown | Micelle BioPharma Inc | 68 | 2017-03-02 | 2019-01-31 |
Anemia, Sickle Cell (2) · Hemoglobin SC Disease (1)
Docosahexaenoic Acids (2) · Soybean Oil (2)
United States (1)
Beng Fuh, MD (1) · Carton Dampier, MD (1) · Matt Heeney, MD (1) · Matthew Heeney, MD (1)